NASDAQ: VRTXVertex Pharmaceuticals Inc Stock Ownership - Who owns Vertex Pharmaceuticals?
Insider buying vs selling
Have Vertex Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David Altshuler | EVP Chief Scientific Officer | 2025-05-15 | 52 | $424.69 | $22.08kSell |
| Sangeeta N. Bhatia | Director | 2025-05-02 | 400 | $505.86 | $202.34kSell |
| David Altshuler | EVP Chief Scientific Officer | 2025-03-13 | 3,231 | $510.00 | $1.65MSell |
| David Altshuler | EVP Chief Scientific Officer | 2025-03-10 | 3,231 | $500.00 | $1.62MSell |
| Charles F. Wagner Jr. | EVP Chief Financial Officer | 2025-03-10 | 3,298 | $500.00 | $1.65MSell |
| Ourania Tatsis | EVP Chief Reg. Quality Off. | 2025-03-10 | 3,242 | $499.99 | $1.62MSell |
| Ourania Tatsis | EVP Chief Reg. Quality Off. | 2025-03-04 | 4,058 | $485.49 | $1.97MSell |
| David Altshuler | EVP Chief Scientific Officer | 2025-03-03 | 3,231 | $490.00 | $1.58MSell |
| Edward Morrow Atkinson Iii | EVP Chief Technical Ops. Off. | 2025-02-27 | 2,650 | $475.34 | $1.26MSell |
| Ourania Tatsis | EVP Chief Reg. Quality Off. | 2025-02-27 | 530 | $475.34 | $251.93kSell |
VRTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VRTX insiders and whales buy or sell their stock.
VRTX Shareholders
What type of owners hold Vertex Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Capital World Investors | 11.11% | 28,533,308 | $13.00B | Institution |
| Vanguard Group Inc | 9.15% | 23,491,161 | $10.70B | Institution |
| Blackrock Inc | 8.48% | 21,782,933 | $9.92B | Institution |
| Capital Research Global Investors | 5.66% | 14,536,344 | $6.62B | Institution |
| State Street Corp | 4.59% | 11,788,657 | $5.37B | Institution |
| Jpmorgan Chase Co | 3.02% | 7,755,645 | $3.53B | Institution |
| Fmr LLC | 3.01% | 7,727,184 | $3.52B | Institution |
| Geode Capital Management LLC | 2.24% | 5,761,760 | $2.62B | Institution |
| Wellington Management Group LLP | 2.12% | 5,454,748 | $2.48B | Institution |
| Jennison Associates LLC | 1.97% | 5,062,442 | $2.31B | Institution |
VRTX vs Biotech Stocks
Vertex Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.